If you could vote on Brexit now which option would you choose?

Arthritis drug effective in treating sickest COVID-19 patients | Imperial News

Critically ill COVID-19 patients treated with an arthritis drug are significantly more likely to have improved outcomes, a study has found. The early findings, which are yet to be published, come from the REMAP-CAP trial, led by Imperial College London and the Intensive Care National Audit & Research Centre (ICNARC) in the UK and Utrecht University in Europe. The trial evaluates the effect of treatments on a combination of survival and length of time patients need support in an intensive care unit (ICU).

Imperial College London - November 19, 2020

View the full story here: https://www.imperial.ac.uk/news/209033/arthritis-drug-effective-treating-sickest-covid-19